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Abstract
Aims This study describes the development
of a score based on cumulative risk factors for
the prediction of severe retinopathy of
prematurity (ROP) comparing the performance
of the score against the birth weight (BW) and
gestational age (GA) in order to predict the
onset of ROP.
Methods A prospective cohort of preterm
infants with BWp1500 g and/or GAp32 weeks
was studied. The score was developed based
on BW, GA, proportional weight gain from
birth to the 6th week of life, use of oxygen in
mechanical ventilation, and need for blood
transfusions from birth to the 6th week of life.
The score was established after linear
regression, considering the impact of each
variable on the occurrences of any stage and
severe ROP. Receiver operating characteristic
(ROC) curves were used to determine the best
sensitivity and specificity values for the score.
All variables were entered into an Excel
spreadsheet (Microsoft) for practical use by
ophthalmologists during screening sessions.
Results The sample included 474 patients.
The area under the ROC curve for the score was
0.77 and 0.88 to predict any stage and severe
ROP, respectively. These values were
significantly higher for the score than for BW
(0.71) and GA (0.69) when measured separately.
Conclusions ROPScore is an excellent index
of neonatal risk factors for ROP, which is easy
to record and more accurate than BW and GA
to predict any stage ROP or severe ROP in
preterm infants. The scoring system is
simple enough to be routinely used by
ophthalmologists during screening
examination for detection of ROP.
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Introduction
Retinopathy of prematurity (ROP) is the most
common disease leading to childhood blindness
among preterm patients in countries reporting
high survival rates.1–3
ROP severe enough to require treatment
usually occurs around the 37–38th
postconceptional week (PCA: defined as
gestational age (GA) at birth plus weeks
of life). There is, therefore, a time interval
during which the occurrence of ROP may be
predicted and the disease may be promptly
treated.
The prevalence of ROP ranges from 0 to 30%,
depending on the quality of neonatal care
delivered to infants and the set of risk factors
that patients present individually. Therefore,
screening programs to detect ROP in preterm
infants at neonatal intensive care units (NICUs),
as well as qualified ophthalmologists to provide
this type of ophthalmologic care, are required to
diagnose the few cases requiring treatment in
order to avoid disease progression and
blindness. Initial ROP screening and eye
examination should be performed between the
4th and 6th weeks after birth, and repeated
according to the findings from baseline
examination every 1 or 2 weeks until retinal
vascularization is completed, around the 42nd
PCA. In case of ROP onset, examinations should
be performed at shorter time intervals.
Appropriate screening sessions are costly and
demand a heavy workload. Moreover, repeated
ophthalmological examinations may lead to
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stress and physical impairment in systemically
compromised infants.
Several risk factors have been reported as involved in
the development of ROP but birth weight (BW) and GA
are considered the most important risk factors for disease
onset.4,5
Severe ROP develops after few weeks of age
(usually around the 36th to 38th PCA) and, in this way,
repeated eye examinations are necessary to detect a
single case of ROP requiring treatment. In order to
reduce the number of eye examinations performed
in preterm infants, we developed a scoring system
(ROPScore) that, if applied at 6 weeks of life, we
hypothesize it may serve as a better predictor than BW
and GA for the occurrence of any stage ROP or ROP
severe enough to require treatment among very low BW
(VLBW) preterm infants. This scoring system will allow
for a reduction in the number of eye examinations
performed in the same patient during ROP screening,
as tests are repeated in those patients who are more
likely to develop the disease. This study describes
the development of ROPScore and compares the
performance of the score against the BW and GA
in order to predict the onset of ROP.
Patients and methods
Study design
This is a prospective institution-based cohort study
including all VLBW preterm infants admitted to the
institution and screened for ROP between October 2002
and July 2009.
Setting
The study was conducted at the NICU of the Hospital
de Clı´nicas de Porto Alegre, a university-based tertiary
hospital, located in an urban area with approximately
3 million inhabitants. Almost all patients are admitted
through the Brazilian Public Health System. In 2002
a neonatal screening program for detection of ROP
was implemented, and since then over 95% of patients
admitted to the NICU are effectively examined once
a week by ophthalmologists.
Population
The sample included all VLBW preterm infants
(born with BWr1500 g and/or GAr32 weeks)
who survived from the initial ophthalmological
examination, performed between the 4th and 6th weeks
after birth, to the 45th PCA. There were no exclusion
criteria.
Clinical outcomes
Clinical outcomes were defined as the onset of any stage
ROP and the development of ROP severe enough to
require treatment. Staging of disease was recorded
according to the 1984/1987 International Classification of
ROP6,7 and always corresponded to the highest stage of
ROP observed during patient follow-up. Severe ROP was
defined according to the Early Treatment for Retinopathy
of Prematurity Randomized Trial.8
Selection of variables to generate ROPScore
The selection of variables to generate ROPScore was
based on an analysis of risk factors for ROP in this cohort
of patients. The 16 variables initially analyzed were: BW;
GA (evaluated by obstetric history, early obstetric
ultrasound, and confirmed by newborn infant clinical
examination); weight gain proportional to BW measured
at 6 weeks of life (defined as the patient’s weight
measured at 6 weeks of life minus BW, divided by BW);
gender; multiple or single gestation; 5-min Apgar score;
use of oxygen in mechanical ventilation or by nasal
continuous positive airway pressure; use of
erythropoietin, indomethacin or surfactant; occurrence of
sepsis, meningitis, patent ductus arteriosus or
intraventricular hemorrhage at any grade; needing for
blood transfusions; and infant small for GA (o10th
percentile). Sepsis and meningitis were diagnosed by
clinical examination and microbiological culture.
Intraventricular hemorrhage was diagnosed by cranial
ultrasound. Clinical diagnosis of sepsis was based on the
presence of three or more of the following signs: apnea,
difficulty breathing, cyanosis, tachycardia or
bradycardia, poor perfusion or shock, irritability,
lethargy, hypotonia or seizures, abdominal distension,
vomiting, diet intolerance, gastric residues,
hepatomegaly, temperature instability or fever, petechiae
or purpura, and appearance of poor health.
Development of ROPScore
All variables selected to generate the score were
considered statistically significant for both ROP
outcomes after univariate analysis and logistic regression
(multivariate analysis). The score was established after
linear regression, taking into account the impact of each
variable in relation to ROP onset.
Statistical analysis
All statistical analyses were performed using the
Statistical Package for the Social Sciences (SPSS),
version 15.0. for Windows (SPSS Inc., Chicago, IL, USA).
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The Student t-test and the w2 test (univariate analysis)
were used to compare patients who developed and who
did not develop ROP (clinical outcomes).
Establishing ROPScore accuracy (sensitivity/specificity)
Receiver operating characteristic (ROC) curve was used
to assess the accuracy of continuous values of the score to
predict any stage or severe ROP, as well as the respective
cutoff points for sensitivity and specificity and the
positive predictive values (PPV) and negative predictive
values (NPV). PPV, in the present study, refers to the
probability of a preterm infant with a score above the
best cutoff point developing ROP, whereas NPV
corresponds to the probability of a preterm infant with a
score below the best cutoff point not developing any
stage and/or severe ROP.9
ROPScore ROC curve results were compared with
ROC curve results for BW and GA individually, because
BW and GA are usually considered the best predictors
of ROP.
Presentation of ROPScore
All variables selected to generate ROPScore were entered
into an Excel spreadsheet (Microsoft) for practical use by
ophthalmologists during screening sessions (Figure 1).
Ethical aspects
The study protocol was approved by the Research Ethics
Committee of the Hospital de Clı´nicas de Porto Alegre
(protocol no. 09-253) and Federal University of Sa˜o
Paulo. The protocol is consistent with the principles of
the Helsinki Declaration of 1995 (revised in Edinburgh
in 2000).
Results
The study included data on 474 patients. Mean BW and
GA for the entire cohort were 1217.3±272 g and 30.3±2.2
weeks. The demographic characteristics of the cohort are
shown in Table 1. The prevalence of any stage ROP in our
sample was 110/474 patients (23.2%). The incidence of
ROP severe enough to require treatment in this study
was 24/474 patients (5.0%).
After univariate analysis for any stage ROP and for
severe ROP, the scoring system was developed based on
BW, GA, proportional weight gain from birth to 6 weeks
of life, use of oxygen in mechanical ventilation, and need
for blood transfusions from birth to 6 weeks of life.
Linear regression analysis of BW, GA, proportional
weight gain, use of mechanical ventilation, and need for
blood transfusions revealed linear coefficients (b) of
0.004, 0.263, 1.258, þ 1.920, and þ 1.980,
respectively. These numbers were applied as weighted
values in the final calculation of the score, as follows:
24.8470.004*C20.263*C31.258*C7þ 1.920*C4þ 1.980*C5.
The final continuous values of the score followed a
parametric distribution, ranging from 9.1 to 21.6, with the
best cutoff point for sensitivity and specificity established
as 11 for ROP and 14.5 for severe ROP. An ROPScore
cutoff point of 11 showed 94% sensitivity, 26% specificity,
a PPV of 28% (95% CI 23.3–32.3), and an NPV of 93%
BW (birth weight) in grams 1000 Use the birth weight in grams
GA (gestational age) in weeks 28 Use the gestational age in weeks
BLOOD TRANSFUSION (up to 6th week of life) 1 Use 0 for none or 1 for yes if the baby underwent any blood transfusion
OXYGEN IN MECHANICAL VENTILATION (up to 6th week of life) 1 Use 0 for none or 1 for yes if the baby underwent oxygen-therapy




16.9 Automatic Calculation / Do not fill in
Automatic Calculation / Do not fill in
Higher the ROPScore = Higher the risk for developing ROP
Cuttoff point for any stage ROP = 11 and for severe ROP = 14.5
NPV (Negative predictive values) = 93% of not developing any stage of ROP and 99% of not developing severe ROP
NPV = probability of a patient with ROPScore below 11 of not developing any stage ROP
NPV = probability of a patient with ROPScore below 14.5 of not developing severe ROP
Figure 1 ROPScore on an Excel spreadsheet for use in clinical practice during screening examinations in preterm infants.
ROPScore: a score composed of cumulative risk factors
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(95% CI 86.8–96.9) for any stage ROP. For severe ROP, a
cutoff point of 14.5 showed 96% sensitivity, 56%
specificity, a PPV of 10.5% (95% CI 7.0–15.1), and an NPV
of 99.6% (95% CI 98.1–99.9).
The area under the ROC curve for ROPScore values
was 0.77 (Po0.001; 95% CI 0.72–0.82) to predict any stage
ROP and 0.88 (Po0.001; 95% CI 0.82–0.94) to predict
severe ROP. These values were significantly higher for
ROPScore than for BW (0.71; Po0.001; 95% CI 0.66–0.77)
and GA (0.69; Po0.001; 95% CI 0.63–0.75), when
measured separately (Table 2).
Discussion
ROP is characterized as a two-phase disease. Phase 1
occurs after premature birth until 30–32 weeks’ PCA and
refers to the interruption in the natural course of retinal
vasculogenesis due to premature birth.10 Phase 2 occurs
between 32 and 34 weeks’ PCA. This phase is
characterized by hypoxia-induced retinal neo-
vascularization similar to that observed in other
proliferative retinopathies.11
Currently, if preterm infants at potential risk of
developing severe ROP were early identified, they could
receive an even more careful and individual perinatal
care concerning their various risk factors. This approach
would facilitate planning the best moment to introduce
eye examination, because sicker children, as well as those
with a worse postnatal prognosis, are at greater risk for
the onset of ROP. This more appropriate perinatal
management of preterm patients at risk of developing
advanced stages of the disease could lead to an efficient
prevention of severe ROP, reducing rates of childhood
blindness.12
Several risk factors have been reported as involved in
the development of ROP, but BW and GA are considered
the most important related risk factors.4,5 ROPScore was
developed based on the main risk factors for the onset of
ROP and it includes data on BW, GA, and weight gain
proportional to BW measured at 6 weeks of life.
Currently, low weight gain after premature birth is
widely accepted as a predictive factor for later
development of ROP, being considered superior to BW
and GA alone as predictors.12–18 In addition, ROPScore
also takes into account the use of oxygen in mechanical
ventilation and the need for blood transfusions. All these
risk factors are involved in the process of ROP
development and can be easily identified by
ophthalmologists during the initial ROP screening eye
examination.19–25
The use of predictive scores is very important in
neonatology. Several scoring systems, from the classic
Apgar score to modern illness severity scores such as
CRIB, SNAP, and SNAPPE-II, are routinely used as
predictors of several comorbidities. Previous studies
have attempted to demonstrate the usefulness of CRIB,
SNAP, and SNAPPE to predict ROP. The authors
reported that none system showed sufficient power to
predict long-term clinical outcomes or ROP-induced
vision impairment, and that cumulative SNAP could be
considered as an independent risk factor for progression
from moderate to severe ROP. However, after adjusting
for other risk factors, cumulative SNAP was unable to
accurately predict the desired outcome (threshold
ROP).26,27
SNAPPE-II has been used as a standard score in the
NICU of our Institution since 2004. SNAPPE-II estimates
illness severity using nine physiological and laboratory
parameters collected within the first 12 h of life of
preterm patients. The score can predict with great
Table 1 Demographic characteristics of all 474 patients included in the study
Total cohort Patients with any stage ROP Patients with severe ROP
Number of patients 474 110 24
Mean BW (g)a 1217.3±272.0 1057.8±271.2 908.7±232.6
Mean GA (weeks)a 30.3±2.2 29.1±2.2 27.9±2.2
Mean WG at the 6th week of life (g)a 637.2±242.1 492.2±205.6 411.7±277.4
ROPScore range (mean±SD) 9.1–21.6 (13.6±2.5) 9.4–21.6 (15.5±2.5) 12.9–20.7 (17.0±1.8)
Abbreviations: BW, birth weight; GA, gestational age; ROP, retinopathy of prematurity; SD, standard deviation; WG, weight gain from birth to 6 weeks
of life.
aData expressed as mean±SD.
Table 2 Area under the ROC curve for ROPScore compared





ROPScore for ROPa 0.77 o0.001 0.72–0.82
BW for ROPa 0.71 o0.001 0.66–0.77
GA for ROPa 0.69 o0.001 0.63–0.75
ROPScore for severe ROP 0.88 o0.001 0.82–0.94
BW for severe ROP 0.82 o0.001 0.73–0.90
GA for severe ROP 0.79 o0.001 0.69–0.88
Abbreviations: BW, birth weight; GA, gestational age; ROP, retinopathy
of prematurity.
aAny stage ROP.
ROPScore: a score composed of cumulative risk factors
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accuracy the risk of mortality during hospitalization and
may also have some importance as an indicator for the
development of other prematurity-related morbidities.
The score had been previously tested by our research
group in order to determine whether it would be a good
predictor for later development of ROP. A positive
association between high SNAPPE-II scores and ROP
onset was observed only after univariate analysis.
However, after adjustments by logistic regression and by
the results obtained using ROC curves, no improvement
was observed in the performance of SNAPPE-II as a
predictor of later onset of ROP compared with BW and
GA.28 A possible explanation for the poor performance
of illness severity scores as predictors of ROP may lie in
the fact that such scores are obtained on the infant’s first
day at the NICU and do not necessarily reflect the clinical
behavior of patients in the weeks that follow premature
birth. Patients with a high SNAPPE-II score, and
consequent increased morbidity on hospital admission,
may frequently have a more stable clinical course
developing less comorbidities. On the other hand,
patients who are healthier at birth, and consequently
have a lower score on admission, may present a much
more unstable clinical course in the weeks following
birth, which may predispose infants to the onset of
ROP.28
In order to be effective in terms of ROP detection, a
scoring system should incorporate variables that take
into account not only the first days after birth, but also
subsequent weeks of life, when several physiological or
pathological processes occur. In this sense, ROPScore
includes weight gain proportional to BW measured at 6
weeks of life, in addition to the use of oxygen in
mechanical ventilation and the need for blood
transfusions up to 6 weeks of life. Thus, in theory, at least
three of the five variables composing the score would be
analyzed in the first 6 weeks of life of patients, unlike BW
and GA that are defined at birth. Recently, clinical
prediction models to early identify patients in risk of ROP
were presented. WINROP29–31 and PINT-ROP32 were
presented using postnatal longitudinal weight gain
measurements. ROPScore, by the other hand, uses the BW
and the weight measured at completed 6 weeks of life as
weighted values in the final calculation of the score.
The accuracy of ROPScore to predict the onset of any
stage ROP or severe ROP was determined by ROC curves
and the respective cutoff points for sensitivity and
specificity of the continuous values of the score. A cutoff
point of 11 was established for any stage ROP and 14.5
for severe ROP. At these cutoff points, ROPScore showed
94% sensitivity and 26% specificity for any stage ROP,
and 96% sensitivity and 56% specificity for severe ROP.
Therefore, the higher the score achieved, the greater the
statistical probability of an infant developing ROP. For
the cutoff point of 11, PPV and NPV for any stage ROP
were established. PPV, in the present study, refers to the
probability of a preterm infant with a score above 11
developing ROP, whereas NPV corresponds to the
probability of a preterm infant with a score below 11 not
developing any stage ROP or severe ROP. Predictive
values at the established cutoff points 11 and 14.5 safely
reflect the global clinical usefulness of the score for the
onset of any stage and severe ROP based on the
prevalence of the disease in the study setting.9
ROPScore is a robust predictor of ROP onset. This
scoring system includes risk factors for ROP that are easy
to record. The score is simple enough to be routinely
used by ophthalmologists or by the NICU staff during
screening examination for detection of ROP. ROPScore is
presented in an Excel spreadsheet (Microsoft) and it can
be used in advance of the first ophthalmological
examination by a member of the NICU staff who inserts
in the respective column the BW in grams (first row) and
the GA in weeks (second row). The numbers 1 or 0 (zero)
should be inserted in the third and fourth rows,
respectively, if the preterm received any blood
transfusion from birth to the 6th week of life (insert
number 1 if the baby received blood transfusion or insert
number 0 if not) and if the preterm used or not used
oxygen-therapy under mechanical ventilation from birth
to the 6th week of life. The last insertion (in the fifth row)
is the baby weight (in grams) at completed 6 weeks of
life. The Excel spreadsheet automatically calculates the
proportional weight gain and the final score for that
considered patient (Figure 1). The staff member presents
for the ophthalmologist the scores for each infant to be
examined in this screening session. According to the
score, the ophthalmologist in charge will decide
which babies should receive more or less frequent
re-evaluations in the weeks following the initial
examination. Higher scores (above 14.5) lead to more
evaluations because these babies have more risk to
develop severe ROP than patients with lower scores. It is
worth to mention that the use of the score did not
influence the usual established criteria for inclusion of
preterm infants in the screening. The ROPScore can be
helpful in order to reduce the excessive number of eye
examinations performed in preterm infants that achieved
low scores.
Summarizing, ROPScore is more accurate than BW and
GA to predict the occurrence of ROP in VLBW preterm
infants. ROPScore is a promising tool that aims to reduce
the excessive number of eye examinations performed in
VLBW preterm infants. Further studies are warranted to
validate the actual usefulness of the score. The internal
validation process of ROPScore is currently underway,
with the score being applied prospectively to our own
patients who are not included in this initial cohort.
ROPScore: a score composed of cumulative risk factors
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The external validation of ROPScore is being conducted
by prospectively applying the score to a cohort of
patients from another population in different countries.
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